ArticleEye and vision (London, England)2016
Scleral resection in chronic central serous chorioretinopathy complicated by exudative retinal detachment.
Article in Eye and vision (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 35 citations in OpenAlex.
- Half-Dose Photodynamic Therapy for Bullous Variant Central Serous Chorioretinopathy: A Long-Term Follow-Up.Ophthalmology and therapy · 2026Article
- Multiple serous retinal detachments after Anti-VEGF Intravitreal Injection for pachychoroid related choroidal neovascularization.American journal of ophthalmology case reports · 2024Article
- Central serous chorioretinopathy and the sclera: what we have learned so far.Japanese journal of ophthalmology · 2024Review
- Pachychoroid disease and its association with retinal vein occlusion: a case-control study.Scientific reports · 2021Article
- A pilot study of scleral thickness in central serous chorioretinopathy using anterior segment optical coherence tomography.Scientific reports · 2021Article
- Vortex Vein Imaging: What Can It Tell Us?Clinical ophthalmology (Auckland, N.Z.) · 2021Review
- Bullous Central Serous Chorioretinopathy: A Rare and Atypical Form of Central Serous Chorioretinopathy. A Systematic Review.Pharmaceuticals (Basel, Switzerland) · 2020Review
- Unusual rapid resolution of postsclerectomy exudative retinal detachment with topical NSAIDs therapy in a case of nanophthalmos.The Journal of international medical research · 2020Article
- Quantitative Assessment of Asymmetric Choroidal Outflow in Pachychoroid Eyes on Ultra-Widefield Indocyanine Green Angiography.Investigative ophthalmology & visual science · 2020Article
- Scleral thinning surgery for bullous retinal detachment with retinal pigment epithelial tear in central serous chorioretinopathy: a case report.BMC ophthalmology · 2020Article
- Serous macular detachment in nanophthalmos: A manifestation of pachychoroid spectrum.American journal of ophthalmology case reports · 2019Article
- Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy.PloS one · 2018Observational
- Subretinal Hypopyon in Presumed Tubercular Uveitis: A Report of Two Cases.Middle East African journal of ophthalmologyArticle
- A Case of Bullous Central Serous Chorioretinopathy Treated with Surgical Removal of Submacular Fibrin and Subsequent Photodynamic Therapy under Silicone Oil.Case reports in ophthalmologyArticle
- Anterior scleral thickness in patients of central serous chorioretinopathy: A Case-control study.Oman journal of ophthalmologyArticle
- Surgical Approaches to Serous Retinal Detachment With Retina-Lens Touch in Eyes With Nanophthalmos.Journal of vitreoretinal diseasesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEffective therapeutic options are limited for the management of chronic central serous chorioretinopathy (CSCR) complicated by exudative retinal detachments (RD). The authors describe the resolution of one such case following partial thickness scleral resection with mitomycin C. CASE PRESENTATION: This 39-year-old male presented with a unilateral inferior exudative RD in the right eye. There was no history of steroid use either locally or systemically. The fundus fluorescein angiogram showed window defects and leaks typical of chronic CSCR. The axial length was 21.06 mm in the right eye and 21 mm in the left eye. Thickening of the ocular coats was evident on ocular ultrasound. Considering an axial length in the borderline-low range inferotemporal and inferonasal partial thickness scleral resection with mitomycin C was performed. The exudative RD resolved at 4 months.
conclusionPartial thickness scleral resection may be considered as an option for treating chronic CSCR patients with borderline-low axial length complicated by exudative RD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.